Events

2021 Info Day and Brokerage Event Horizon Europe Cluster 2
JUL
Thu
01
JUL
Fri
02

This was 5 years ago

Location

Online

Programmes
Culture and society

The European Commission has announced that the online info day for Horizon Europe Cluster 2 - Culture, Creativity and Inclusive Society will take place on 1 July 2021 from 9:00 to 13:15. During this session the call topics of Cluster 2 will be presented and there will be an opportunity to ask questions.

More information on the programme and web streaming can be found on this link.

In addition to this info day, an online brokerage event for Cluster 2 will be organized on 2 July 2021 from 10:00 to 14:00. This matchmaking event will give the participants the opportunity to virtually meet and find potential consortium partners.

More information on this brokerage event and registration can be found on the event’s website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.